BOSTON SCIENTIFIC CORPORATION Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
BOSTON SCIENTIFIC CORPORATION (BSX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $119.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-12-31 was $53.00M.
- BOSTON SCIENTIFIC CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $119.00M, a 1.71% increase from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $117.00M, a 4.88% decline from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $123.00M, a 186.05% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $43.00M, a 36.76% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|
| 2025-12-31 | $119.00M 10-K · filed 2026-02-17 | ||
| 2024-12-31 | $117.00M 10-K · filed 2026-02-17 | ||
| 2023-12-31 | $123.00M 10-K · filed 2025-02-18 | ||
| 2022-12-31 | $43.00M 10-K · filed 2024-02-20 | ||
| 2021-12-31 | $68.00M 10-K · filed 2023-02-23 | ||
| 2020-12-31 | $202.00M 10-K · filed 2022-02-23 | ||
| 2019-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $137.00M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $84.00M 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |